Alpha Crest Capital Management LLC Bridge Bio Pharma, Inc. Transaction History

Alpha Crest Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$7.34 - $17.16 $142,124 - $332,269	-19,363 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$11.38 - $53.41 $121,709 - $571,219	10,695 Added 123.38%	19,363 $323,000
Q3 2021 Nov 10, 2021	SELL	$46.87 - $64.24 $1.23 Million - $1.69 Million	-26,293 Reduced 75.21%	8,668 $406,000
Q2 2021 Aug 12, 2021	BUY	$46.47 - $63.93 $1.06 Million - $1.46 Million	22,861 Added 188.93%	34,961 $2.13 Million
Q1 2021 May 13, 2021	BUY	$55.47 - $72.35 $349,461 - $455,804	6,300 Added 108.62%	12,100 $745,000
Q4 2020 Feb 12, 2021	BUY	$38.38 - $71.11 $222,604 - $412,438	5,800 New	5,800 $412,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.45B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.